CONNECTS Master Protocol for Clinical Trials targeting macro-, micro-immuno-thrombosis, vascular hyperinflammation, and hypercoagulability and renin-angiotensin-aldosterone system (RAAS) in hospitalized patients with COVID-19 (ACTIV-4 Host Tissue)
Details
Age
Adult
Type of Study
Treatment
Locations
Denver Health and Hospital Authority
Principal Investigator
Ivor Douglas, MD
Study ID
Protocol Number: 21-3728-DH
More information available at ClinicalTrials.gov: NCT04924660
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers